Asia Tides Oligonucleotides and Peptide Therapeutics Forum 2026
Date: Tue, Feb 24, 2026 – Thu, Feb 26, 2026
No content found
Asia Tides Oligonucleotides and Peptide Therapeutics Forum will be held from February 24–26, 2026 at Grand Nikko Tokyo Daiba, Japan. The forum covers technologies and solutions for oligonucleotides, peptides, mRNA, genome editing, and contract manufacturing/development services for mid-molecular drugs. Hosting 55 exhibitors, 60+ speakers, and 2 pre-conference workshops, it gathers 300 professionals to share strategies across discovery, development, and CMC. Organized by Informa Connect, the event provides insights into next-generation therapeutics and fosters collaboration among leaders in RNA and peptide drug development.
Conference Themes & Discussion Topics
Pre-Conference Workshops (Feb 24, AM)
- Regulatory and Practical CMC Considerations for Novel RNA Chemistries
- Manufacturing and Characterization of Long or Complex Peptides
Main Conference Day 1 (Feb 24, PM)
- Keynotes on siRNA, TMOs, GLP-1 and mRNA therapeutics
- Emerging scale-up and clinical development strategies
Main Conference Day 2 (Feb 25)
- Oligonucleotide and Peptide tracks: formulation, synthesis, downstream processing, and analytical methods
- Networking luncheons, poster sessions, and TIDES Talks
Main Conference Day 3 (Feb 26)
- Delivery strategies, advanced RNA approaches, mRNA and oligonucleotide platforms
- Latest preclinical and clinical case studies, antibody-oligo conjugates, and peptide discovery technologies
Topics Covered:
- Oligonucleotide and peptide synthesis innovations
- Advanced purification and analytical characterization
- CMC and regulatory strategies
- mRNA and genome editing therapeutics
- Contract manufacturing and scalable production solutions
Range of Exhibition
- Nucleic Acid & RNA Therapeutics:
Oligonucleotides, mRNA, genome editing technologies, drug delivery solutions. - Peptide Therapeutics:
Peptides, synthesis, characterization, purification, and formulation technologies. - Services & Contract Development:
Contract manufacturing and development for oligonucleotides, peptides, and mid-molecular drugs, analytical services, and regulatory support.
Target Audience
Biopharma executives, R&D scientists, process development managers, regulatory affairs specialists, formulation scientists, CMC professionals, contract manufacturing experts, academic researchers, biotech entrepreneurs, and healthcare innovators.
Related Events
